With novel genome-wide technologies it is nowadays possible to perform detailed molecular analyses of normal and malignant tissues. Acute myeloid leukemia (AML) is a heterogeneous group of diseases with variable response to therapy. Gene expression profiling and genome-wide genotyping have recently been successfully applied to unravel the heterogeneity of AML. This chapter gives instructions and recommendations for genome-wide gene expression analyses, genotyping, and copy number analyses, as performed for AML using Affymetrix GeneChips. © Springer Science+Business Media, LLC 2013.
CITATION STYLE
Sanders, M. A., & Valk, P. J. M. (2013). Genome-wide gene expression profiling, genotyping, and copy number analyses of acute myeloid leukemia using affymetrix genechips. Methods in Molecular Biology, 1015, 155–177. https://doi.org/10.1007/978-1-62703-435-7_10
Mendeley helps you to discover research relevant for your work.